Nanthealth Financial Statements From 2010 to 2022

NH
 Stock
  

USD 0.56  0.02  3.45%   

Nanthealth financial statements provide useful quarterly and yearly information to potential Nanthealth investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nanthealth financial statements helps investors assess Nanthealth's valuation, profitability, and current liquidity needs.
We have found one hundred seven available fundamental ratios for Nanthealth, which can be analyzed and compared to other ratios and to its peers in the industry. Please verify all of Nanthealth last-minute fundamental drivers against the trend between 2010 and 2022 to make sure the company can sustain itself down the road.
Nanthealth Invested Capital is most likely to decrease significantly in the upcoming years. The last year's value of Invested Capital was reported at 114.78 Million. The current Invested Capital Average is estimated to increase to about 221.7 M, while Net Income Per Employee is projected to decrease to (439.1 K).
  
Check Nanthealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanthealth main balance sheet or income statement drivers, such as Direct Expenses of 39.3 M, Cost of Revenue of 37.4 M or Gross Profit of 47.2 M, as well as many exotic indicators such as Long Term Debt to Equity of 68.76, PPandE Turnover of 5.16 or Receivables Turnover of 8.08. Nanthealth financial statements analysis is a perfect complement when working with Nanthealth Valuation or Volatility modules. It can also supplement Nanthealth's financial leverage analysis and stock options assessment as well as various Nanthealth Technical models . Additionally, see the analysis of Nanthealth Correlation against competitors.

Nanthealth Revenues

73.43 Million

Nanthealth Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets421.4 M329.3 M362.3 M
Increasing
Very volatile
Cash and Equivalents16.9 M16.5 M25.8 M
Increasing
Stable
Investments29.3 M28.5 M144.9 M
Decreasing
Slightly volatile
Investments Current1.1 M1.1 M86.1 M
Decreasing
Slightly volatile
Investments Non Current29.3 M28.5 M155 M
Decreasing
Slightly volatile
Deferred Revenue1.4 M1.4 M20.5 M
Decreasing
Slightly volatile
Property Plant and Equipment Net23.2 M23.7 M16.4 M
Increasing
Slightly volatile
Inventory458.1 K446.4 K1.7 M
Decreasing
Slightly volatile
Tax Assets89.7 K75.6 K110.3 K
Decreasing
Slightly volatile
Trade and Non Trade Receivables7.2 M4.6 M8.5 M
Increasing
Stable
Trade and Non Trade Payables9.3 M8.4 M13.4 M
Decreasing
Slightly volatile
Goodwill and Intangible Assets173.8 M168.2 M125.9 M
Increasing
Slightly volatile
Total Liabilities215.9 M255.2 M184 M
Increasing
Slightly volatile
Shareholders Equity3.3 M3.3 M157.3 M
Decreasing
Slightly volatile
Accumulated Other Comprehensive Income(155.2 K)(151.2 K)(38.8 K)
Decreasing
Slightly volatile
Current Assets46.6 M45.4 M129 M
Decreasing
Slightly volatile
Assets Non Current198.7 M152.7 M202.3 M
Increasing
Slightly volatile
Current Liabilities52.2 M42 M59.6 M
Decreasing
Slightly volatile
Liabilities Non Current209.3 M215 M124.8 M
Increasing
Slightly volatile
Tax Liabilities1.9 M1.7 M2.1 M
Increasing
Slightly volatile
Total Debt236 M254.3 M144.5 M
Increasing
Slightly volatile
Debt Current124.4 M115.3 M39.5 M
Increasing
Slightly volatile
Debt Non Current135 M108.8 M178 M
Decreasing
Slightly volatile
Shareholders Equity USD(103.3 M)(100.6 M)57.2 M
Decreasing
Slightly volatile
Cash and Equivalents USD27.4 M20.5 M26 M
Increasing
Stable
Total Debt USD236 M254.3 M144.5 M
Increasing
Slightly volatile
Accounts Payable1.9 M1.9 M3.5 M
Decreasing
Slightly volatile
Receivables12 M13.8 M9.5 M
Increasing
Slightly volatile
Inventories585.4 K570.4 K1.7 M
Decreasing
Slightly volatile

Nanthealth Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues73.4 M80.5 M64.4 M
Increasing
Slightly volatile
Cost of Revenue37.4 M33.6 M31.2 M
Increasing
Slightly volatile
Selling General and Administrative Expense50.5 M43.7 M56.6 M
Increasing
Stable
Research and Development Expense18.1 M15.5 M20.5 M
Increasing
Very volatile
Operating Expenses74 M63.2 M91.7 M
Decreasing
Slightly volatile
Interest Expense18.1 M22.1 M9.4 M
Increasing
Slightly volatile
Income Tax Expense554.6 K514 K(2.2 M)
Decreasing
Very volatile
Net Loss Income from Discontinued Operations(29.6 M)(28.8 M)11.9 M
Decreasing
Slightly volatile
Weighted Average Shares131.2 M125.5 M114 M
Increasing
Slightly volatile
Weighted Average Shares Diluted131.2 M125.5 M114 M
Increasing
Slightly volatile
Revenues USD84.6 M84.1 M60.9 M
Increasing
Slightly volatile
Gross Profit47.2 M50.5 M29.7 M
Increasing
Slightly volatile
Direct Expenses39.3 M39.8 M37.1 M
Increasing
Slightly volatile

Nanthealth Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals50.8 M47.1 M(7.6 M)
Increasing
Stable
Net Cash Flow Investment Acquisitions and Disposals(446.7 K)(414 K)(77.7 M)
Increasing
Slightly volatile
Net Cash Flow from Financing(2.5 M)(2.5 M)135.6 M
Decreasing
Slightly volatile
Issuance Repayment of Debt Securities 12 K11.7 K16.7 M
Decreasing
Very volatile
Issuance Purchase of Equity Shares157.9 K153.9 K122.1 M
Decreasing
Slightly volatile
Effect of Exchange Rate Changes on Cash (57.3 K)(55.8 K)(8.2 K)
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents17.3 M16 M(1 M)
Increasing
Very volatile
Share Based Compensation2.4 M2.4 MM
Increasing
Very volatile
Depreciation Amortization and Accretion22.8 M19.3 M19.9 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Gross Margin40.7245.4738.5325
Increasing
Slightly volatile
Asset Turnover0.190.220.1883
Increasing
Slightly volatile
Sales per Share0.970.940.876
Decreasing
Very volatile
Price to Sales Ratio4.424.418.9652
Decreasing
Slightly volatile
Price to Book Value(2.97)(2.89)2.4758
Decreasing
Stable
Debt to Equity Ratio68.7663.7326.7446
Increasing
Slightly volatile
Current Ratio1.821.241.999
Decreasing
Slightly volatile
Book Value per Share(0.93)(0.91)0.6486
Decreasing
Slightly volatile
Tangible Assets Book Value per Share0.450.442.2997
Decreasing
Slightly volatile
Total Assets Per Share3.973.014.4985
Decreasing
Slightly volatile
Receivables Turnover8.087.687.1194
Increasing
Stable
Inventory Turnover57.2353.0430.3036
Increasing
Slightly volatile
PPandE Turnover5.164.964.7298
Decreasing
Slightly volatile
Cash and Equivalents Turnover3.712.576.707
Decreasing
Slightly volatile
Accounts Payable Turnover36.0933.4521.5307
Increasing
Slightly volatile
Accrued Expenses Turnover10.3412.538.8829
Increasing
Slightly volatile
Long Term Debt to Equity68.7663.7326.8614
Increasing
Slightly volatile
Quick Ratio0.840.821.7016
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets1.21.1720.5474
Decreasing
Slightly volatile
Revenue to Assets0.220.280.1896
Increasing
Slightly volatile

Nanthealth Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization344.3 M323.3 M766.7 M
Decreasing
Slightly volatile
Enterprise Value498.5 M498.5 M865.7 M
Decreasing
Slightly volatile
Invested Capital175.9 M114.8 M228.1 M
Decreasing
Very volatile
Average Equity(74 M)(72.1 M)95 M
Decreasing
Slightly volatile
Average Assets273.1 M199.1 M359.9 M
Decreasing
Slightly volatile
Invested Capital Average221.7 M188.2 M250.6 M
Increasing
Very volatile
Tangible Asset Value49.9 M48.6 M204.4 M
Decreasing
Slightly volatile
Working Capital(87 M)(84.7 M)47.1 M
Decreasing
Slightly volatile
Revenue Per Employee132.4 K148.3 K112.6 K
Increasing
Slightly volatile

Nanthealth Fundamental Market Drivers

Short Percent Of Float1.15%
Forward Price Earnings-2.00
Shares Short Prior Month1.01M
Average Daily Volume Last 10 Day34.79k
Average Daily Volume In Three Month121.72k
Date Short Interest15th of July 2022
Fifty Day Average0.5121
Two Hundred Day Average0.8612

Nanthealth Upcoming Events

Upcoming Quarterly Report24th of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Nanthealth Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Nanthealth income statement, its balance sheet, and the statement of cash flows. Nanthealth investors use historical funamental indicators, such as Nanthealth's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nanthealth investors may use each financial statement separately, they are all related. The changes in Nanthealth's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nanthealth's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Nanthealth Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Nanthealth. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Deferred Revenue1.4 M1.4 M
Cost of Revenue33.6 M37.4 M
Revenues80.5 M73.4 M
Revenue to Assets 0.28  0.22 
Revenue Per Employee148.3 K132.4 K
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Nanthealth operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 326 people.

Nanthealth Investors Sentiment

The influence of Nanthealth's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Nanthealth. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Nanthealth's public news can be used to forecast risks associated with investment in Nanthealth. The trend in average sentiment can be used to explain how an investor holding Nanthealth can time the market purely based on public headlines and social activities around Nanthealth. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Nanthealth's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Nanthealth's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Nanthealth's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Nanthealth.

Nanthealth Implied Volatility

    
  0.0  
Nanthealth's implied volatility exposes the market's sentiment of Nanthealth stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nanthealth's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nanthealth stock will not fluctuate a lot when Nanthealth's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nanthealth in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nanthealth's short interest history, or implied volatility extrapolated from Nanthealth options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nanthealth using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see the analysis of Nanthealth Correlation against competitors. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
64.6 M
Quarterly Revenue Growth YOY
0.025
Return On Assets
-0.15
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.